A team of scientists based in the US has used solid–phase microextraction (SPME) and gas chromatography–mass spectrometry (GC–MS) to provide the first analysis of volatile organic compounds (VOCs) present in human earwax (cerumen).1
A team of scientists based in the US has used solid-phase microextraction (SPME) and gas chromatography–mass spectrometry (GC–MS) to provide the first analysis of volatile organic compounds (VOCs) present in human earwax (cerumen).1
There are between 1000 and 2000 ceruminous glands in the ear, keeping the eardrum lubricated, waterproof, and cleaning the external auditory canal. Cerumen also has antibacterial properties and can reduce the viability of a range of bacteria. The team also investigated and compared cerumen prof les of subjects of East Asian and Caucasian descent. Cerumen from Caucasian subjects is a wet, yellow-brown colour; while East Asian subjects have a dry, white wax. Lead author of the study, Katharine Prokop-Prigge, told The Column: “Earwax, until now, has been a little-studied human secretion. We have found important information contained in human earwax, specifically information about the ethnicity of a person simply by looking in his ears.”
The team sampled the headspace of earwax samples from 16 male subjects by using SPME. The earwax sample was first transferred to glass vials and incubated at body temperature for 30 min. This allowed the release of volatiles into the headspace of the vial. The SPME fibre was then exposed in the vial’s headspace for an additional 30 min. The compounds adsorbed onto the fibre were separated and identified using GC–MS. While the analysis was relatively straightforward, Prokop-Prigge revealed to The Column that one issue arose during the course of the experiment. “The different earwax types, wet vs. dry, provided very different matrices for dissolving and subsequently releasing an internal standard. To get around this, we employed an external standard injected on the GC–MS prior to each sample to account for daily variation in GC–MS responses”, she said.
The principal odourants emitted were C2-to-C6 acids. The study found that the two groups emitted many of the same VOCs but the relative amounts were found to be greater in the Caucasian group in relation to the East Asian results. Prokop-Prigge concluded: “Our lab has studied human odours and the information they contain for years. In this study, we wanted to examine ‘a new frontier of human odour’ and possibly uncover unique information about a person by examining his/her earwax.” - K.M.
Reference
1. K.A. Prokop-Prigge et al., Journal of Chromatography B, http://dx.doi.org/10.1016/j.jchromb.2014.01.043 (2014).
This article first appeared in The Column. Click to view and print this issue>>
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.